Sign up to save your podcasts
Or
Share Under the microscope: Antisense Therapeutics (ASX:ANP) - Mark Diamond, Managing Director
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Under the microscope: Antisense Therapeutics (ASX:ANP) - Mark Diamond, Managing Director
Morgans Research Analyst Iain Wilkie talks with Mark Diamond, Managing Director of Antisense Therapeutics (ASX:ANP). Mark shares a recap on what the company does, and what potential investors can look out for.
View all episodes
By Morgans Financial LimitedMorgans Research Analyst Iain Wilkie talks with Mark Diamond, Managing Director of Antisense Therapeutics (ASX:ANP). Mark shares a recap on what the company does, and what potential investors can look out for.